risedronate sodium hemi-pentahydrate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
5 FDA-registered drug labelers
Allergan, Inc.
Apotex Inc.
Aurobindo Pharma Limited
Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd
Sun Pharmaceutical Industries, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •risedronate sodium
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS329003-65-8
PubChem CID11954322
DTXSIDDTXSID601382970
FormulaC14H30N2Na2O19P4
Mol. Weight700.26 g/mol
SMILESC1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].O.O.O.O.O.[Na+].[Na+]
Data Sources
119543222026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/risedronate sodium hemi-pentahydrate/cids/JSON
Archive: data/sources/pubchem_name/risedronate sodium hemi-pentahydrate.json
CAS 329003-65-82026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json